Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement On October 6, 2025, CV Sciences, Inc., a Delaware corporation (the “Company”) entered into a note purchase agreement
Financial Statements and Exhibits (d) Exhibits 10.1 Securities Purchase Agreement dated October 6, 2025 (confidential portions of the exhibit have been omitted